Prof. Abu-Elmagd obtained his undergraduate degree and M.Sc. from Department of Zoology, Faculty of Science, Al-Minia University, Egypt in Developmental Biology. In 2002, he was awarded his PhD in Developmental Molecular Biology (Molecular Embryology) by the University of Nottingham, Institute of Genetics, School of Medicine. After that he took up a Senior Research Associate position at the School of Biological Sciences, University of East Anglia, UK before joining Center of Excellence in Genomic Medicine Research (CEGMR), King Abdulaziz University, Saudi Arabia as an Associate Professor in 2012. In 2019 Dr. Abu-Elmagd was appointed as a Professor.
Prof. Abu-Elmagd’s research focuses on the study of gene expression and regulation during early embryonic development with the aim of understanding the molecular mechanisms that control early developmental events. Prof. Abu-Elmagd is particularly interested in the analysis of genes that could play a dual role during the embryonic development as well as in regulating human diseases. Prof. Abu-Elmagd established the Functional and Developmental Genomics unit at CEGMR in which he applies different experimental approaches including in vivo and in vitro gain- and loss-of-function. Prof. Abu-Elmagd analyses his data using a wide range of advanced platforms including microarray, next generation sequencing, proteomics, flowcytometry and highly advanced cellular imaging.
Prof. Abu-Elmagd has numerous scientific achievements which have been featured outstanding publications (http://www.ncbi.nlm.nih.gov/pubmed/?term=Abu-Elmagd+m). Organised by CEGMR, Prof. Abu-Elmagd led the editorial board of the 2nd and 3rd International Genomic Medicine Conference (IGMC) in 2015 and 2016. Prof. Abu-Elmagd has established a prestigious open access journal (npj Genomic Medicine) in partnership with one of the world’s leading scientific publishers, Nature Publishing Group, and he is an editor of this journal. Prof. Abu-Elmagd is setting on two Nature Journal Management Committees (npj Genomic Medicine and npj Climate and Atmospheric Science). Prof. Abu-Elmagd served as a guest editor to BMC Genomics and currently is a guest editor to Frontiers in Genetics.
- Kharrat N, Assidi M, Abu-Elmagd M, Pushparaj P, Alkhaldy A, Arfaoui L, Naseer M, El Omri A, Messaoudi S, Buhmeida A, Rebai A. (2019). Data mining analysis of human gut microbiota links Fusobacterium spp. with colorectal cancer onset. Bioinformation 15(6): 372-379.
- Kalamegam G, Sait KHW, Ahmed F, Kadam R, Pushparaj PN, Anfinan N, Rasool M, Jamal MS, Abu-Elmagd M, Al-Qahtani M. (2018). Human Wharton's Jelly Stem Cell (hWJSC) Extracts Inhibit Ovarian Cancer Cell Lines OVCAR3 and SKOV3 in vitro by Inducing Cell Cycle Arrest and Apoptosis. Front Oncol. 7;8:592. doi: 10.3389/fonc.2018.00592.
- Abu-Elmagd M (2018). Use of chick neural tube for optimising the PSM and epithelial somites electroporation parameters: A detailed protocol. J Biol. Meth. (Accepted in 29th March, 2018) (In Press, DOI: 10.14440/jbm.%Y.253).
- Naseer MI, Alwasiyah MK, Abdulkareem AA, Bajammal RA, Trujillo C, Abu‑Elmagd M, Jafri MA, Chaudhary AG, Al‑Qahtani MH (2018). A novel homozygous mutation in SZT2 gene in Saudi family with developmental delay, macrocephaly and epilepsy. Genes & Genomics. 23rd February 2018. (Impact Factor: 1.566) (DOI: 10.1007/s13258-018-0673-5).
- Bahamat AA, Assidi M, Lary SA, Almughamsi MM, Peer Zada AA, Chaudhary A, Abuzenadah A, Abu-Elmagd M, Al-Qahtani M (2018). Use of array comparative genomic hybridization for the diagnosis of Digeorge syndrome in Saudi Arabian population. Cytog Genom Res. February 17, 2018. (Impact factor: 1.354) (DOI: 10.1159/000487094).
- Abu-Elmagd M, Joanna Mulvaney, Grant Wheeler. (2017). Frizzled-7 is required for Xenopus heart development. Biol Open. 2017 Nov 3. pii: bio.026963. (Impact factor: 2.50) (DOI: 10.1242/bio.026963)
- Abu-Elmagd M, Alghamdi MA, Shamy M, Khoder MI, Costa M, Assidi M, Kadam R, Alsehli H, Gari M, Pushparaj PN, Kalamegam G, Al-Qahtani MH. (2017). Evaluation of the effects of airborne particulate matter on Bone Marrow-Mesenchymal Stem Cells (BM-MSCs): Cellular, molecular and systems biological approaches. Int. J Environ Res Public Health. 20;14(4). pii: E440. (Impact factor: 2.101) (DOI: 10.3390/ijerph14040440).